Endometrial changes from short-term therapy with CDB-4124, a selective progesterone receptor modulator
article
OA: bronze
CC0
⤵ 26 in-corpus citations
AI-generated summary
This study examined endometrial histological and morphological changes in response to short-term treatment with CDB-4124, a selective progesterone receptor modulator.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (26)
- Asoprisnil (J867): a selective progesterone receptor modulator for gynecological therapy via openalex
- Effect of long-term treatment with low-dose mifepristone on the endometrium via openalex
- Progesterone receptor modulators and the endometrium: changes and consequences† via openalex
- Selective progesterone receptor modulators and progesterone antagonists: mechanisms of action and clinical applications via openalex
- W1988229883 via openalex
- W2002239473 via openalex
- W2026392453 via openalex
- W2039633328 via openalex
- W2043933121 via openalex
- W2045180596 via openalex
- W2047203443 via openalex
- W2078370543 via openalex
- W2095904930 via openalex
- W2122146138 via openalex
- W2126884778 via openalex
- W2153497318 via openalex
- W2156181845 via openalex
- W2172094497 via openalex
- W2204640292 via openalex
- W2317410898 via openalex
- W4237330062 via openalex
- W1967005912 via openalex
- W6674568298 via openalex
- W1982488750 via openalex
- W1984592479 via openalex
- W1984901643 via openalex
Cited by (26)
- Distinct clinicopathological features of ovarian endometriosis after long-term exposure to mifepristone 2022
- Selective progesterone receptor modulators and reproductive health 2022
- Roles of microRNAs in Regulating Apoptosis in the Pathogenesis of Endometriosis 2022
- Selective Progesterone Receptor Modulators (SPRMs) and Androgen Receptor Modulators (SARMs) as Treatment for Benign Gynecologic Diseases 2021
- Hepatotoxizität selektiver Progesteronrezeptormodulatoren 2021
- Endometrial Calcifications 2020
- Endometriosis: advances and controversies in classification, pathogenesis, diagnosis, and treatment 2019
- Benign Uterine Diseases 2019
- Is it time for a paradigm shift in drug research and development in endometriosis/adenomyosis? 2018
- Ulipristal acetate therapy increases ultrasound features of adenomyosis: a good treatment given in an erroneous diagnosis of uterine fibroids 2018
- Endometrial Changes in Surgical Specimens of Perimenopausal Patients Treated With Ulipristal Acetate for Uterine Leiomyomas 2017
- On-label and off-label drug use in the treatment of endometriosis 2015
- Novel Medical Treatment Modalities of Endometriosis 2015
- Innovations in classical hormonal targets for endometriosis 2015
- Experimental Treatments of Endometriosis 2015
- Medical Treatments for Endometriosis-Associated Pelvic Pain 2014
- Progesterone Resistance and Targeting the Progesterone Receptors: A Therapeutic Approach to Endometriosis 2012
- Progesterone Receptor Modulators Induce Apoptosis in Mammary Tumors and Uterine Leiomyomas 2012
- Biomarkers in reproductive medicine: the promise, and can it be fulfilled? 2012
- The Translational Efficacy of a Nonsteroidal Progesterone Receptor Antagonist, 4-[3-Cyclopropyl-1-(mesylmethyl)-5-methyl-1H-pyrazol-4-yl]oxy,-2,6-dimethylbenzonitrile (PF-02413873), on Endometrial Growth in Macaque and Human 2011
- Population Pharmacokinetics of Telapristone (CDB-4124) and its Active Monodemethylated Metabolite CDB-4453, with a Mixture Model for Total Clearance 2011
- Selective progesterone receptor modulators in reproductive medicine: pharmacology, clinical efficacy and safety 2011
- Mifepristone: where do we come from and where are we going? 2010
- CDB-4124, a Progesterone Receptor Modulator, Inhibits Mammary Carcinogenesis by Suppressing Cell Proliferation and Inducing Apoptosis 2010
- Intrauterine progestins, progesterone antagonists, and receptor modulators: a review of gynecologic applications 2009
- Clinical utility of progesterone receptor modulators and their effect on the endometrium 2009
Source provenance
- europepmc
- last seen: 2026-06-13T06:22:48.782012+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:14:18.065553+00:00
License: CC0
· commercial use OK